Inhibition of LPS- and CpG DNA-induced TNF-α response by oxidized phospholipids

被引:62
作者
Ma, Z
Li, J
Yang, LJ
Mu, Y
Xie, W
Pitt, B
Li, S
机构
[1] Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15213 USA
关键词
reactive oxygen intermediates; 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine; innate immune response;
D O I
10.1152/ajplung.00220.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Lipid oxidation is commonly seen in the innate immune response, in which reactive oxygen intermediates are generated to kill pathogenic microorganisms. Although oxidation products of phospholipids have generally been regarded to play a role in a number of chronic inflammatory processes, several studies have shown that oxidized phospholipids inhibit the LPS-induced acute proinflammatory response in cultured macrophages and endothelial cells. We report in this study that oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (PAPC), but not nonoxidized PAPC, significantly inhibits the LPS-induced TNF-alpha response in intact mice. Oxidized PAPC also inhibits the 2'-deoxyribo(cytidine-phosphate-guanosine) (CpG) DNA-induced TNF-alpha response in cultured macrophages and intact mice. To elucidate the mechanisms of action, we show that oxidized PAPC, but not nonoxidized PAPC, inhibits the LPS- and CpG-induced activation of p38 MAPK and the NF-kappaB cascade. These results suggest a role for oxidized lipids as a negative regulator in controlling the magnitude of the innate immune response. Further studies on the mechanisms of action may lead to development of a new type of anti-inflammatory drug for treatment of acute inflammatory diseases such as sepsis.
引用
收藏
页码:L808 / L816
页数:9
相关论文
共 54 条
[1]   Toll-like receptors in the induction of the innate immune response [J].
Aderem, A ;
Ulevitch, RJ .
NATURE, 2000, 406 (6797) :782-787
[2]   Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA2-IIA expression in alveolar macrophages through NF-κB and PPAR-γ-dependent pathways [J].
Alaoui-El-Azher, M ;
Wu, YZ ;
Havet, N ;
Israël, A ;
Lilienbaum, A ;
Touqui, L .
MOLECULAR PHARMACOLOGY, 2002, 61 (04) :786-794
[3]  
Alleva DG, 2002, J LEUKOCYTE BIOL, V71, P677
[4]  
Barton GM, 2002, CURR TOP MICROBIOL, V270, P81
[5]   Lipid oxidation products and atherosclerosis [J].
Berliner, J .
VASCULAR PHARMACOLOGY, 2002, 38 (04) :187-191
[6]   ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[7]   Protective role of phospholipid oxidation products in endotoxin-induced tissue damage [J].
Bochkov, VN ;
Kadl, A ;
Huber, J ;
Gruber, F ;
Binder, BR ;
Leitinger, N .
NATURE, 2002, 419 (6902) :77-81
[8]   Oxidized phlospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT [J].
Bochkov, VN ;
Mechtcheriakova, D ;
Lucerna, M ;
Huber, J ;
Malli, R ;
Graier, WF ;
Hofer, E ;
Binder, BR ;
Leitinger, N .
BLOOD, 2002, 99 (01) :199-206
[9]  
Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36
[10]   PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation [J].
Chawla, A ;
Barak, Y ;
Nagy, L ;
Liao, D ;
Tontonoz, P ;
Evans, RM .
NATURE MEDICINE, 2001, 7 (01) :48-52